Long-Term Vision for Approximately ¥10 Billion in Revenue
First written in FY2022-Q1. 2 of 4 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2018: 3 of 26 companies on the "Worse" side.
12 other companies' latest entry also says "Dropped".
- FY2023DroppedAnnual reportThe long-term vision of revenue of ¥10 billion set out in previous filings is not included in the management policy or medium- to long-term strategy in this filing.
- FY2022-Q3RestatedAnnual report
「Within the business areas of the existing Healthcare Solutions Business and Global Environmental Solutions Business segments, we will develop businesses and projects based on a business diversification strategy and aim to achieve our long-term vision of revenue of ¥10 billion.」
The company continues to pursue its long-term vision of targeting revenue of ¥10 billion by diversifying businesses and projects within its 2 existing segments. - FY2022-Q2RestatedAnnual report
「Within the business areas of the existing Healthcare Solutions Business and Global Environmental Solutions Business segments, we will develop businesses and projects based on a business diversification strategy and aim to achieve our long-term vision of revenue of ¥10 billion.」
The company continues to pursue its long-term vision of targeting revenue of ¥10 billion by diversifying businesses and projects within its 2 existing segments. - FY2022-Q1First statedAnnual report
「Within the business areas of the existing Healthcare Solutions Business and Global Environmental Solutions Business segments, we will develop businesses and projects based on a business diversification strategy and aim to achieve our long-term vision of revenue of ¥10 billion.」
The company has presented for the first time a long-term vision targeting revenue of ¥10 billion by diversifying businesses and projects within its 2 existing segments.